Celcuity Investor Relations Material
Latest events
Q1 2025
Celcuity
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Celcuity Inc
Access all reports
Celcuity Inc. is a biotechnology company focused on developing diagnostic tests to improve the treatment of cancer. The company specializes in functional cellular analysis, using its proprietary CELsignia platform to identify molecular and cellular changes in a patient’s cancer cells. This technology helps detect new cancer subtypes and matches patients with targeted therapies that are most likely to be effective. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
CELC
Country
🇺🇸 United States